1
|
Rigaud VOC, Hoy RC, Kurian J, Zarka C, Behanan M, Brosious I, Pennise J, Patel T, Wang T, Johnson J, Kraus LM, Mohsin S, Houser SR, Khan M. RNA-Binding Protein LIN28a Regulates New Myocyte Formation in the Heart Through Long Noncoding RNA-H19. Circulation 2023; 147:324-337. [PMID: 36314132 PMCID: PMC9870945 DOI: 10.1161/circulationaha.122.059346] [Citation(s) in RCA: 9] [Impact Index Per Article: 9.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 01/25/2022] [Accepted: 10/17/2022] [Indexed: 01/29/2023]
Abstract
BACKGROUND Developmental cardiac tissue holds remarkable capacity to regenerate after injury and consists of regenerative mononuclear diploid cardiomyocytes. On maturation, mononuclear diploid cardiomyocytes become binucleated or polyploid and exit the cell cycle. Cardiomyocyte metabolism undergoes a profound shift that coincides with cessation of regeneration in the postnatal heart. However, whether reprogramming metabolism promotes persistence of regenerative mononuclear diploid cardiomyocytes enhancing cardiac function and repair after injury is unknown. Here, we identify a novel role for RNA-binding protein LIN28a, a master regulator of cellular metabolism in cardiac repair after injury. METHODS LIN28a overexpression was tested using mouse transgenesis on postnatal cardiomyocyte numbers, cell cycle, and response to apical resection injury. With the use of neonatal and adult cell culture systems and adult and Mosaic Analysis with Double Markers myocardial injury models in mice, the effect of LIN28a overexpression on cardiomyocyte cell cycle and metabolism was tested. Last, isolated adult cardiomyocytes from LIN28a and wild-type mice 4 days after myocardial injury were used for RNA-immunoprecipitation sequencing. RESULTS LIN28a was found to be active primarily during cardiac development and rapidly decreases after birth. LIN28a reintroduction at postnatal day (P) 1, P3, P5, and P7 decreased maturation-associated polyploidization, nucleation, and cell size, enhancing cardiomyocyte cell cycle activity in LIN28a transgenic pups compared with wild-type littermates. Moreover, LIN28a overexpression extended cardiomyocyte cell cycle activity beyond P7 concurrent with increased cardiac function 30 days after apical resection. In the adult heart, LIN28a overexpression attenuated cardiomyocyte apoptosis, enhanced cell cycle activity, cardiac function, and survival in mice 12 weeks after myocardial infarction compared with wild-type littermate controls. Instead, LIN28a small molecule inhibitor attenuated the proreparative effects of LIN28a on the heart. Neonatal rat ventricular myocytes overexpressing LIN28a mechanistically showed increased glycolysis, ATP production, and levels of metabolic enzymes compared with control. LIN28a immunoprecipitation followed by RNA-immunoprecipitation sequencing in cardiomyocytes isolated from LIN28a-overexpressing hearts after injury identified long noncoding RNA-H19 as its most significantly altered target. Ablation of long noncoding RNA-H19 blunted LIN28a-induced enhancement on cardiomyocyte metabolism and cell cycle activity. CONCLUSIONS Collectively, LIN28a reprograms cardiomyocyte metabolism and promotes persistence of mononuclear diploid cardiomyocytes in the injured heart, enhancing proreparative processes, thereby linking cardiomyocyte metabolism to regulation of ploidy/nucleation and repair in the heart.
Collapse
Affiliation(s)
- Vagner Oliveira Carvalho Rigaud
- Center for Metabolic Disease Research (V.0.C.R., R.C.H., J.K., C.Z., M.B., I.B., J.P., T.P., M.K.), Lewis Katz School of Medicine, Temple University, Philadelphia, PA
| | - Robert C Hoy
- Center for Metabolic Disease Research (V.0.C.R., R.C.H., J.K., C.Z., M.B., I.B., J.P., T.P., M.K.), Lewis Katz School of Medicine, Temple University, Philadelphia, PA
| | - Justin Kurian
- Center for Metabolic Disease Research (V.0.C.R., R.C.H., J.K., C.Z., M.B., I.B., J.P., T.P., M.K.), Lewis Katz School of Medicine, Temple University, Philadelphia, PA
| | - Clare Zarka
- Center for Metabolic Disease Research (V.0.C.R., R.C.H., J.K., C.Z., M.B., I.B., J.P., T.P., M.K.), Lewis Katz School of Medicine, Temple University, Philadelphia, PA
| | - Michael Behanan
- Center for Metabolic Disease Research (V.0.C.R., R.C.H., J.K., C.Z., M.B., I.B., J.P., T.P., M.K.), Lewis Katz School of Medicine, Temple University, Philadelphia, PA
| | - Isabella Brosious
- Center for Metabolic Disease Research (V.0.C.R., R.C.H., J.K., C.Z., M.B., I.B., J.P., T.P., M.K.), Lewis Katz School of Medicine, Temple University, Philadelphia, PA
| | - Jennifer Pennise
- Center for Metabolic Disease Research (V.0.C.R., R.C.H., J.K., C.Z., M.B., I.B., J.P., T.P., M.K.), Lewis Katz School of Medicine, Temple University, Philadelphia, PA
| | - Tej Patel
- Center for Metabolic Disease Research (V.0.C.R., R.C.H., J.K., C.Z., M.B., I.B., J.P., T.P., M.K.), Lewis Katz School of Medicine, Temple University, Philadelphia, PA
| | - Tao Wang
- Center for Cardiovascular Research (T.W., J.J., L.M.K., S.M., S.R.H.), Lewis Katz School of Medicine, Temple University, Philadelphia, PA
| | - Jaslyn Johnson
- Center for Cardiovascular Research (T.W., J.J., L.M.K., S.M., S.R.H.), Lewis Katz School of Medicine, Temple University, Philadelphia, PA
| | - Lindsay M Kraus
- Center for Cardiovascular Research (T.W., J.J., L.M.K., S.M., S.R.H.), Lewis Katz School of Medicine, Temple University, Philadelphia, PA
| | - Sadia Mohsin
- Center for Cardiovascular Research (T.W., J.J., L.M.K., S.M., S.R.H.), Lewis Katz School of Medicine, Temple University, Philadelphia, PA
| | - Steven R Houser
- Center for Cardiovascular Research (T.W., J.J., L.M.K., S.M., S.R.H.), Lewis Katz School of Medicine, Temple University, Philadelphia, PA
| | - Mohsin Khan
- Center for Metabolic Disease Research (V.0.C.R., R.C.H., J.K., C.Z., M.B., I.B., J.P., T.P., M.K.), Lewis Katz School of Medicine, Temple University, Philadelphia, PA
- Department of Cardiovascular Sciences (M.K.), Lewis Katz School of Medicine, Temple University, Philadelphia, PA
| |
Collapse
|
2
|
Rigaud VO, Hoy R, Kurian J, Zarka C, Behanan M, Brosious I, Pennise J, Patel TK, Kraus L, Mohsin S, Houser SR, Khan M. Abstract P1030: LIN28a-induced Metabolic Reprogramming Regulates New Myocyte Formation In The Heart Via Lncrna-H19. Circ Res 2022. [DOI: 10.1161/res.131.suppl_1.p1030] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
Abstract
Developmental cardiac tissue holds remarkable capacity to regenerate after injury and consists of regenerative mononuclear and diploid cardiomyocytes (MNDCMs). Upon maturation, MNDCMs become binucleated or polyploid and exit the cell cycle. Interestingly, CM metabolism undergoes a profound shift that coincides with cessation of regeneration in the postnatal heart. However, whether reprogramming metabolism promotes persistence of regenerative MNDCMs enhancing cardiac function and repair after injury is unknown. Here, we identify a novel role for RNA-binding protein LIN28a, a master regulator of cellular metabolism, in cardiac repair following injury. LIN28a was found as primarily active during cardiac development and rapidly decreases after birth. LIN28a reintroduction at P1, P3, P5, and P7 decreased maturation-associated polyploidization, nucleation, and cell size, enhancing CM cell cycle activity in LIN28a transgenic pups compared to WT littermates. Moreover, LIN28a overexpression extended CM cell cycle activity beyond P7 concurrent with increased cardiac function 30 days after apical resection. In the adult heart, LIN28a overexpression attenuated CM apoptosis, enhanced cell cycle activity, cardiac function, and survival in mice 12 weeks after myocardial infarction compared to WT littermate controls. Alternatively, LIN28a small molecule inhibitor attenuated pro-reparative effects of LIN28a on the heart. Mechanistically, Neonatal rat ventricular myocytes (NRVMs) overexpressing LIN28a showed increased glycolysis, ATP production and levels of metabolic enzymes compared to control. LIN28a immunoprecipitation followed by RNA sequencing (RIPseq) in CMs isolated from LIN28a injured hearts identified lncRNA-H19 as its most significantly altered target. Ablation of lncRNA-H19 blunted LIN28a-induced enhancement on CM metabolism and cell cycle activity. Collectively, LIN28a reprograms CM metabolism and promotes persistence of MNDCMs in the injured heart enhancing pro-reparative processes thereby linking CM metabolism to regulation of ploidy/nucleation and repair in the heart.
Collapse
|